IL10 and neoplasm: Other components of metabolic pathways maintaining an immunosuppressive environment, such as IDO and cytokines like IL-10 and TGFβ, impair anti-tumor immune responses by disrupting DC differentiation, migration, and antigen presentation, necessary for T-cell priming, making them promising targets for anti-tumor responses [441,442].